<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03913247</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL19_0031</org_study_id>
    <nct_id>NCT03913247</nct_id>
  </id_info>
  <brief_title>Evaluation of Methods for Extrapolating or Estimating the Size of Children in Pediatric Intensive Care</brief_title>
  <acronym>EvTaReaP</acronym>
  <official_title>Evaluation of Methods for Extrapolating or Estimating the Size of Children in Pediatric Intensive Care Compared With the Reference Method of the World Health Organization (WHO)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Size is a key data used daily by dietary teams; the paramedical team, nurse and diet are in
      charge of its measures.

      In pediatric intensive care unit, a reliable size of the child must be obtained. It allows to
      realize:

        -  a nutritional assessment based on the World Health Organization (WHO) nutritional
           indices such as the Body Mass Index (BMI), growth chart monitoring and other nutritional
           indices. Nutritional status should be assessed and followed in pediatric intensive care
           as it is correlated with the prognosis of children.

        -  an estimate of the energy needs by calculation of the rest energy expenditure.

        -  a calculation of the body surface, useful for drug prescription, evaluation of burn
           scores, calculation of water and energy requirements and indexing of hemodynamic and
           ventilatory data.

      An error in size measurement results in an error in BMI, calculation of energy requirements,
      and body surface area.

      The WHO has defined &quot;gold standard&quot; criteria for measuring height in children, distinguishing
      the less than two years in whom the size is measured strictly lengthened, using a metric, and
      the more than two years in which height is measured standing with a stadiometer. In the
      context of pediatric resuscitation, the criteria for WHO size measurement are difficult to
      meet (coma, sedation, respiratory assistance, catheter, monitoring, proclive position, etc.)
      compromising standing or rectitude required for measurements.

      The child is a growing organism. Health book sizes and declarative sizes are not always
      up-to-date.

      It is therefore important to overcome these difficulties by using estimating or extrapolation
      methods that are applicable and safe in pediatric intensive care unit.

      Currently, in pediatric intensive care units, the size evaluation, by direct measurement,
      estimation or extrapolation of segmental measurement, is not systematic because of the
      complexity of the measurement; To date, no method is used as a reference method in pediatric
      intensive care.

      Among Children in pediatric intensive care unit (which does not usually meet the criteria of
      the WHO Gold Standard for Measurement of Height), to determine the optimal method for size
      measurement, by comparing different methods of estimating / extrapolating the size, gold
      standard WHO (achievable after the stay in intensive care).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 29, 2019</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>reliability of a series of extrapolation measurement techniques or size estimation in pediatric intensive care units.</measure>
    <time_frame>150 days</time_frame>
    <description>The reliability of the estimation / size extrapolation methods will be defined by the average relative error relative to the WHO gold standard. A method will be considered reliable and without clinical impact if the absolute value of the average relative error is less than 3.5%</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">462</enrollment>
  <condition>Pediatric Intensive Care Unit</condition>
  <arm_group>
    <arm_group_label>Group with different size measures</arm_group_label>
    <description>Each patient included in the study will have different measure of size.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Size Measurement using a measuring tape, a caliper and a metric</intervention_name>
    <description>Each patient will have the following measure: measure of the span, the tibia, the ulna, the distance between the hill and the knee, the head, the trunk and the leg. The different measures will be done using a measuring tape and with a caliper. Before leaving the intensive care unit, each patients will be measured according to the WHO standard, that is to say strictly lengthened, using a metric for patient younger than 2 and stand up using a stadiometer for patient older than 2.</description>
    <arm_group_label>Group with different size measures</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients in pediatric intensive care unit
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children aged from 28 days to 18 years old.

          -  Admitted in pediatric intensive care unit with a resuscitation situation (at least one
             system failure including respiratory and/or hemodynamic and/or neurological).

          -  Children whose size was not measurable, at the time of the admission in pediatric
             intensive care unit according to WHO standards.

          -  Patient affiliated to a social security system

        Exclusion Criteria:

          -  No expected evolution to a clinical state allowing the size measure according to the
             WHO standards according to age.

          -  Stature growth greater (defined by WHO growth velocity scale according to age and sex)
             than 5% before the expected delay allowing the size measure using the WHO standards
             according to age

          -  Children with skeleton malformation, dwarfism, abnormal limb.

          -  Expected death before the end of the stay in pediatric intensive care unit

          -  Parents or patients able to answer, refusing to participate to the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carole Ford-Chessel</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospices Civils de Lyon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Carole Ford-Chessel</last_name>
    <phone>4 27 85 59 55</phone>
    <phone_ext>+33</phone_ext>
    <email>carole.ford-chessel@chu-lyon.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julien Berthiller</last_name>
    <phone>4 27 85 63 01</phone>
    <phone_ext>+33</phone_ext>
    <email>julien.berthiller@chu-lyon.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service de réanimation pédiatrique Hôpital Reine Fabiola Hôpital Publique</name>
      <address>
        <city>Brussels</city>
        <zip>1020</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Shancy ROOZE, Dr</last_name>
      <phone>04 77 32 40</phone>
      <phone_ext>+32</phone_ext>
      <email>Shancy.ROOZE@huderf.be</email>
    </contact>
    <investigator>
      <last_name>Shancy ROOZE, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de réanimation pédiatrique Centre hospitalier universitaire de Bordeaux</name>
      <address>
        <city>Bordeaux</city>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul NOLENT, Dr</last_name>
      <phone>02 53 48 23 09</phone>
      <phone_ext>+33</phone_ext>
      <email>paul.nolent@chu-bordeaux.fr</email>
    </contact>
    <contact_backup>
      <last_name>Karine MOUNEYDIER</last_name>
      <phone>02 53 48 23 09</phone>
      <phone_ext>+33</phone_ext>
      <email>karine.mouneydier@chu-bordeaux.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Paul NOLENT, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Karine MOUNEYDIER</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Femme Mère Enfant</name>
      <address>
        <city>Bron</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carole Ford-Chessel</last_name>
      <phone>4 27 85 59 55</phone>
      <phone_ext>+33</phone_ext>
      <email>carole.ford-chessel@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Frédéric VALLA, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carole Ford-Chessel</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de réanimation et de surveillance continue pédiatrique CHRU de Lille</name>
      <address>
        <city>Lille</city>
        <zip>59000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Camille GUILLOT, Dr</last_name>
      <phone>06 67 87 54 88</phone>
      <phone_ext>+33</phone_ext>
      <email>camille.guillot@chru-lille.fr</email>
    </contact>
    <investigator>
      <last_name>Camille GUILLOT, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de réanimation pédiatrique CHU La Timone AP-HM</name>
      <address>
        <city>Marseille</city>
        <zip>13005</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael TSAPIS, Dr</last_name>
      <phone>04 91 38 48 99</phone>
      <phone_ext>+33</phone_ext>
      <email>Michael.tsapis@ap-hm.fr</email>
    </contact>
    <contact_backup>
      <last_name>Anne-Sophie DUPRET</last_name>
      <email>Anne-sophie.DUPRET@ap-hm.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Michael TSAPIS, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne-Sophie DUPRET</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de réanimation pédiatrique Centre hospitalier universitaire de Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bénédicte GAILLARD LEROUX, Dr</last_name>
      <phone>02 53 48 23 09</phone>
      <phone_ext>+33</phone_ext>
    </contact>
    <investigator>
      <last_name>Bénédicte GAILLARD LEROUX, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de réanimation pédiatrique Rue Du Morvan (CHRU NANCY - HOPITAUX DE BRABOIS)</name>
      <address>
        <city>Vandœuvre-lès-Nancy</city>
        <zip>54500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mathieu MARIA, Dr</last_name>
      <phone>03.83.15.46.98</phone>
      <phone_ext>+33</phone_ext>
      <email>m.maria@chru-nancy.fr</email>
    </contact>
    <investigator>
      <last_name>Mathieu MARIA, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de réanimation pédiatrique Hôpital de l'hôtel dieu de France</name>
      <address>
        <city>Beirut</city>
        <country>Lebanon</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elie CHOUEIRY, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Elie CHOUEIRY, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Haute école de santé - HES-SO Genève</name>
      <address>
        <city>Geneva</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Corinne JOTTERAND-CHAPARRO, PhD</last_name>
      <phone>22 388 34 60</phone>
      <phone_ext>+41</phone_ext>
      <email>corinne.jotterand@hesge.ch</email>
    </contact>
    <contact_backup>
      <last_name>Clemence MOULLET</last_name>
      <phone>22 388 34 60</phone>
      <phone_ext>+41</phone_ext>
      <email>clemence.moullet@hesge.ch</email>
    </contact_backup>
    <investigator>
      <last_name>Corinne JOTTERAND-CHAPARRO, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
    <country>Lebanon</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>April 10, 2019</study_first_submitted>
  <study_first_submitted_qc>April 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2019</study_first_posted>
  <last_update_submitted>March 20, 2020</last_update_submitted>
  <last_update_submitted_qc>March 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metronidazole</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

